import
monitor
humananim
nexu
emerg
zoonot
pathogen
gain
abil
cross
speci
barrier
especi
true
among
highrisk
occup
set
anim
worker
close
prolong
contact
mani
anim
recent
agricultur
profession
routin
contact
product
anim
shown
increas
risk
zoonot
infect
often
experi
symptomat
ill
meng
et
al
olsen
et
al
koopman
et
al
myer
et
al
gray
baker
gray
et
al
gray
et
al
b
kayali
et
al
dog
popular
companion
anim
canin
industri
lessstudi
occup
set
overcrowd
shelter
breed
kennel
creat
perfect
environ
zoonot
diseas
continu
emerg
threaten
human
anim
health
overcrowd
shelter
breed
kennel
creat
perfect
environ
amplifi
infecti
diseas
transmiss
among
dog
present
critic
opportun
zoonot
pathogen
emerg
infect
peopl
work
close
contact
dog
coronavirus
widespread
preval
extens
host
rang
variou
diseas
manifest
increas
frequenc
recombin
event
underlin
potenti
interspeci
transmiss
method
mol
biol
object
studi
determin
whether
peopl
occup
contact
dog
like
antibodi
canin
respiratori
coronaviru
crcov
compar
person
dog
exposur
seroepidemiolog
cohort
studi
complet
canineexpos
noncanineexpos
studi
subject
enrol
studi
provid
serum
sampl
complet
selfadminist
questionnair
competit
enzymelink
immunosorb
assay
elisa
develop
detect
human
antibodi
crcov
control
crossreact
antibodi
human
coronaviru
studi
subject
neg
antibodi
crcov
competit
elisa
studi
support
premis
human
risk
crcov
infect
howev
infrequ
crossspeci
transmiss
crcov
rule
amplifi
infecti
diseas
transmiss
among
dog
critic
opportun
zoonot
pathogen
emerg
infect
peopl
work
close
contact
dog
first
identifi
unit
kingdom
canin
respiratori
coronaviru
crcov
newli
emerg
host
variant
enter
canin
coronaviru
ccov
similar
coronavirus
undergo
genet
evolut
crcov
evolv
accumul
point
mutat
insert
delet
within
coronaviru
genom
decaro
buonavoglia
follow
discoveri
evid
crcov
infect
seroposit
document
dog
variou
clinic
histori
japan
itali
new
zealand
korea
canada
unit
state
crcov
play
role
canin
infecti
respiratori
diseas
complex
cird
kennel
cough
consid
enzoot
among
dog
popul
priestnal
et
al
erl
brownli
human
infect
crcov
never
report
studi
investig
evid
crcov
infect
human
seroepidemiolog
cohort
studi
conduct
unit
state
sought
test
hypothesi
dog
worker
would
higher
preval
antibodi
crcov
compar
nondogexpos
control
studi
approv
univers
iowa
univers
florida
institut
review
board
target
popul
includ
breeder
kennel
employe
veterinari
personnel
anim
shelter
worker
greyhound
racetrack
employe
dog
show
handler
whose
work
hobbi
involv
exposur
multipl
dog
nonexpos
nonmatch
control
group
consist
individu
neither
expos
multipl
dog
part
work
hobbi
pet
dog
household
last
year
particip
least
year
age
selfreport
current
immunocompromis
condit
recruit
base
conveni
sampl
target
popul
primarili
iowa
florida
breeder
shelter
veterinari
clinic
identifi
state
databas
licens
breeder
practic
veterinarian
well
internet
search
organ
staff
invit
particip
studi
via
mail
letter
telephon
call
followup
enrol
typic
occur
particip
place
employ
recruit
also
occur
larg
public
venu
includ
dog
show
agil
trial
trade
show
nonexpos
control
faculti
staff
student
univers
iowa
univers
florida
inform
consent
obtain
particip
complet
selfadminist
questionnair
permit
collect
blood
specimen
via
venipunctur
singl
encount
questionnair
collect
demograph
data
specif
dog
exposur
data
behaviour
data
includ
person
hygien
practic
care
dog
dogyear
exposur
specif
occup
hobbi
calcul
multipli
averag
number
dog
subject
came
close
contact
given
day
occupationhobbi
total
year
work
occupationhobbi
whole
blood
specimen
transport
ice
laboratori
within
hour
collect
blood
tube
centrifug
g
min
room
temperatur
separ
serum
collect
serum
aliquot
frozen
cultur
crcov
hcov
use
captur
antigen
antagonist
competit
elisa
human
colorect
adenocarcinoma
cell
line
atcc
catalog
propag
modifi
roswel
park
memori
institut
rpmi
media
rpmi
gibco
invitrogen
carlsbad
ca
usa
mm
hepe
buffer
fisher
scientif
pittsburgh
pa
usa
foetal
bovin
serum
fb
glucos
mm
sodium
pyruv
mgml
streptomycin
fisher
scientif
iu
penicillin
fisher
scientif
previous
describ
erl
et
al
crcov
polymeras
chain
reaction
pcr
posit
canin
respiratori
swab
provid
dr
edward
dubovi
cornel
univers
dilut
rpmi
infect
media
fb
drop
use
inocul
suspens
freshli
trypsin
cell
suspens
incub
h
co
rock
platform
infect
suspens
seed
onto
cell
cultur
flask
corn
corn
ny
usa
ml
infect
media
ad
cell
allow
adher
mockinfect
flask
cell
includ
neg
control
day
cell
reach
confluenc
harvest
previous
describ
priestnal
et
al
propag
crcov
also
attempt
two
canin
respiratori
tract
cell
line
howev
viral
titr
never
surpass
threshold
provid
cultur
cell
attempt
obtain
higher
titr
crcov
serial
passag
cell
observ
viral
passag
titr
would
dramat
decreas
therefor
develop
competit
elisa
viru
passag
cell
use
use
antagonist
competit
elisa
human
coronaviru
hcov
also
propag
cell
briefli
cell
seed
cell
cultur
flask
corn
upon
reach
confluenc
monolay
wash
three
time
plain
rpmi
media
invitrogen
inocul
ml
hcov
passag
attc
tcid
ml
dilut
rpmi
infect
media
addit
ml
rpmi
infect
media
ad
cell
incub
co
cytopath
effect
cpe
observ
microscop
h
viru
stock
save
passag
later
blind
passag
describ
without
recalcul
tcid
ml
ensur
fresh
viral
cultur
supernat
use
competit
elisa
mockinfect
flask
includ
neg
control
realtim
rtpcr
detect
crcov
cell
cultur
realtim
revers
transcript
polymeras
chain
reaction
qrtpcr
perform
proprietari
primer
probe
obtain
univers
wisconsin
detect
presenc
crcov
cell
cultur
rna
extract
cell
cultur
supernat
qiaamp
viral
rna
mini
kit
qiagen
valencia
ca
usa
infect
cell
rneasi
mini
kit
qiagen
accord
manufactur
instruct
one
step
qrtpcr
run
use
superscript
iii
revers
transcriptas
platinum
taq
invitrogen
follow
condit
min
min
cycl
cycl
threshold
c
valu
examin
determin
number
cycl
requir
fluoresc
signal
cross
threshold
background
level
per
previou
report
priestnal
et
al
protein
concentr
crcov
hcov
neg
control
cell
lysat
determin
pierc
coomassi
bradford
uk
colorimetr
protein
assay
kit
thermo
fisher
scientificpierc
biotechnolog
rockford
il
usa
accord
manufactur
instruct
optic
densiti
sampl
determin
use
powerwav
autom
micropl
spectrophotomet
biotek
winooski
vt
usa
referenc
standard
curv
bovin
serum
albumin
protein
concentr
report
lgml
extrapol
detect
crcov
antibodi
human
sera
also
control
crossreact
antibodi
hcov
elisa
design
detect
crcov
antibodi
canin
serum
erl
et
al
priestnal
et
al
adapt
sera
crcovposit
crcovneg
dog
use
posit
neg
assay
control
crcovinfect
uninfect
control
cell
cultur
lysat
dilut
approxim
lgml
protein
carbonatebicarbon
buffer
ph
dilut
antigen
suspens
ad
altern
duplic
column
clear
flat
bottom
highbind
immulon
polystyren
microtit
plate
thermo
scientif
rochest
ny
usa
plate
seal
prevent
evapor
contamin
incub
overnight
optim
protein
bind
next
plate
wash
three
time
phosphatebuff
salin
pb
block
addit
solut
nonfat
milk
nestl
carnat
wilkesbarr
pa
usa
pb
h
room
temperatur
plate
wash
pb
undilut
human
sera
mix
hcov
cultur
supernat
incub
h
mixtur
dilut
dilut
buffer
nonfat
milk
tween
fisher
scientif
pb
result
final
dilut
sera
ad
plate
duplic
well
coat
crcovinfect
uninfect
cell
cultur
lysat
elisa
plate
incub
h
wash
three
time
wash
buffer
tween
pb
detect
human
igg
bound
plate
accomplish
addit
goat
antihuman
igg
conjug
horseradish
peroxidas
hrp
kpl
dilut
dilut
buffer
ad
well
block
human
sera
ad
detect
dog
igg
posit
neg
control
well
rabbit
antidog
igg
conjug
conjug
hrp
sigmaaldrich
st
loui
mo
usa
dilut
ad
control
well
follow
incub
room
temperatur
plate
wash
three
time
wash
buffer
detect
hrpconjug
antibodi
bound
plate
accomplish
addit
tetramethylbenzidin
peroxidas
substrat
tmb
kpl
incub
dark
room
temperatur
tmb
reaction
stop
addit
n
sulphur
acid
fisher
scientif
within
min
stop
reaction
absorb
read
nm
wavelength
use
powerwav
autom
micropl
spectrophotomet
biotek
valu
duplic
well
crcovcoat
uninfect
cell
control
well
averag
serum
sampl
serum
sampl
consid
posit
antibodi
crcov
averag
absorb
crcov
well
exceed
three
standard
deviat
averag
absorb
control
well
student
ttest
use
compar
continu
variabl
wald
chisquar
test
use
compar
categor
variabl
logist
regress
use
compar
optic
densiti
od
level
exposur
group
ascertain
odd
ratio
associ
confid
interv
analysi
perform
use
sa
sa
institut
cari
nc
usa
total
canineexpos
subject
noncanineexpos
control
grant
inform
consent
complet
enrol
questionnair
submit
serum
sampl
demograph
gender
distribut
ident
exposur
group
control
tend
younger
expos
group
mean
year
old
respect
overal
particip
like
women
resid
iowa
florida
major
enrol
took
place
tabl
illustr
workhobbi
involv
close
contact
approxim
ft
dog
report
particip
respond
allow
indic
one
occup
hobbi
singl
occupationhobbi
involv
median
dogyear
exposur
breeder
tend
median
three
breed
femal
kennel
serolog
evid
previou
exposur
crcov
among
studi
popul
base
upon
result
competit
elisa
frequenc
mean
od
level
indic
appar
outlier
addit
signific
differ
mean
od
level
averag
test
well
averag
neg
control
well
standard
deviat
two
group
mean
od
canineexpos
subject
nonexpos
control
signific
differ
group
examin
continu
od
data
od
level
categor
quartil
tabl
canineposit
control
serum
mean
od
standard
deviat
neg
control
well
canineneg
control
serum
mean
od
variat
cov
host
rang
specif
pathogenesi
attribut
spike
glycoprotein
gallagh
buchmeier
entri
bodi
cov
attach
specif
cellular
receptor
via
spike
protein
weiss
navasmartin
crcov
transmit
inhal
infect
aerosol
droplet
howev
pathogenesi
dog
still
unknown
crcov
like
elicit
subclin
asymptomat
diseas
dog
damag
respiratori
epithelium
viral
replic
may
lead
clinic
secondari
infect
respiratori
pathogen
buonavoglia
martella
crcov
may
also
function
primari
pathogen
infect
priestnal
et
al
crcov
spike
protein
gain
affin
human
respiratori
epitheli
cell
receptor
hcov
employ
weiss
navasmartin
crcov
could
potenti
replic
human
cell
caus
human
infect
base
current
publish
literatur
first
studi
examin
possibl
zoonot
infect
crcov
among
human
howev
result
show
evid
previou
exposur
crcov
among
immunocompet
adult
antibodi
crcov
detect
differ
elisa
od
dog
worker
unexpos
control
crossreact
substanti
obstacl
overcom
design
serolog
assay
competit
elisa
develop
control
crossreact
antibodi
detect
specif
antibodi
crcov
group
hcov
chosen
crcov
elisa
competitor
owe
high
amino
acid
ident
variou
viral
protein
homolog
erl
et
al
lorusso
et
al
strain
hcov
close
relat
crcov
phylogenet
analys
kaneshima
et
al
therefor
consid
like
crossreact
crcov
antibodi
tabl
serolog
result
human
antibodi
canin
respiratori
coronaviru
base
optic
densiti
od
read
expos
nonexpos
studi
group
studi
number
limit
key
limit
factor
inher
imperfect
natur
serolog
assay
design
antibodi
rigidli
specif
infect
one
viru
bacterium
render
person
immun
attack
close
relat
pathogen
thu
reduc
incid
infect
although
fortuit
natur
present
difficult
obstacl
serolog
diagnos
complet
control
crossreact
antibodi
often
unachiev
epidemiolog
studi
frequent
employ
comparison
group
statist
adjust
control
limit
case
studi
approach
overcom
lack
antibodi
specif
seen
crcov
neg
result
studi
suggest
sever
possibl
scenario
one
studi
popul
previous
expos
crcov
could
extrapol
suggest
crcov
develop
zoonot
capabl
ii
assay
sensit
insuffici
detect
true
posit
iii
iggonli
secondari
antibodi
detect
exist
igm
antibodi
indic
recent
exposur
possibl
low
level
antibodi
crcov
present
human
sera
hcov
crossreact
crcov
antibodi
prevent
detect
anoth
signific
limit
examin
novel
zoonot
transmiss
infecti
diseas
lack
proper
posit
neg
assay
control
exist
human
sera
known
human
case
crcov
furthermor
crossreact
antibodi
hcov
caus
common
cold
keyaert
et
al
well
distantli
relat
enter
hcov
make
find
truli
nonexpos
neg
control
sera
difficult
well
without
human
serum
control
studi
employ
canin
serum
basi
assay
success
appropri
essenti
studi
potenti
zoonot
diseas
parallel
ideal
canin
serum
intrins
differ
human
serum
secondari
antibodi
antidog
igg
antihuman
igg
requir
individu
optim
addit
lack
preval
data
crcov
among
dog
studi
area
weaken
strength
studi
without
preval
data
crcov
canin
popul
difficult
distinguish
whether
neg
result
indic
pathogen
zoonot
whether
peopl
expos
crcov
first
place
seroepidemiolog
studi
limit
often
employ
valid
first
step
examin
potenti
zoonot
spread
anim
pathogen
spite
aforement
studi
limit
studi
novelti
public
health
signific
made
implement
worthwhil
